Les dernières recommandations du
Comité de Nutrition
Christophe Dupont (Paris)
12h15-12h45
Lorigine précoce des maladies chroniques de ladulte
[Early origins of adult disease]. Simeoni U, Bocquet A,
Briend A, Chouraqui JP, Darmaun D, Dupont C, Feillet F,
Frelut ML, Girardet JP, Goulet O, Hankard R, Rieu D, Rozé JC,
Turck D, Vidailhet M; Comité de nutrition de la Société
française de pédiatrie. Arch Pediatr. 2016 May;23(5):443-6.
Vitamin A in pediatrics: An update from the Nutrition
Committee of the French Society of Pediatrics. Vidailhet
M, Rieu D, Feillet F, Bocquet A, Chouraqui JP, Darmaun D,
Dupont C, Frelut ML, Girardet JP, Hankard R, Rozé JC,
Simeoni U, Turck D, Briend A. Arch Pediatr. 2017
Mar;24(3):288-297.
Impact of obesity on biomarkers of iron and
vitamin D status in children and adolescents:
the risk of misinterpretation.
Frelut ML, Girardet JP, Bocquet A, Briend A,
Chouraqui JP, Darmaun D, Dupont C, Feillet F,
Hankard R, Rozé JC, Simeoni U; Committee on
Nutrition of the French Society of Paediatrics.
Arch Pediatr. 2018 Jan;25(1):3-5.
Editorial
Reviewing the current evidence on
iron and vitamin D status in obese
children, and the interpretation of
the biomarkers in this population
Iron status in obese children
studies based on several iron-status
biomarkers showed a consistent increase
in the prevalence, risk, and severity of
iron deficiency in overweight and obese
children and adolescents in industrialized
and in some emerging countries,
especially in girls after menarche.
Hutchinson C. A review of iron studies in overweight and obese children
and adolescents: a double burden in the young? Eur J Nutr 2016;55:2179
97.
Iron status in obese children
The iron status in obese children seems to be more
related to a deviation of iron metabolism to
reticuloendothelial system and to inflammation-
related ferritin oversynthesis ...
Therefore, iron supplementation is poorly efficient
in treating the microcytic anemia observed in obese
children because iron is not well absorbed because of
chronic inflammation.
Even if the response to oral supplementation may be
less effective in obese than in normal-weight
children [1,9], obese children should be screened
for iron deficiency because of its deleterious effects.
Which markers for iron deficiency in
obese children?
Serum ferritin, the best indicator of iron stores
in the general population, is increased in obese
patients because of the associated chronic
inflammation.
This may in turn lead to an underestimation of
iron deficiency [7].
the NHANES III study, using serum ferritin as
one of the diagnostic criteria of iron deficiency,
reports a lower prevalence rate in obese children
and adolescents, compared to other studies
[4,6,7].
Obesity and vitamin D status
In overweight and obese children and
adolescents, plasma 25(OH)D concentrations
lower than in normal-weight children ...
based on 25(OH)D plasma concentrations, the
prevalence of vitamin D deficiency is 35% higher
in obese children and adolescents, and 24%
higher in overweights , compared to normal-
weight , irrespective of age, latitude, and
25(OH)D cut-offs used to define deficiency [2].
Obesity and vitamin D status
Low plasma 25(OH)D concentrations do not
necessarily reflect true deficiency.
They may be due to increased storage in
adipose tissue, impaired vitamin D release
from adipose tissue, or a lower bioavailability
of vitamin D synthesized in the skin despite
adequate UV-B exposure through yet
unknown mechanisms, as reported in obese
adults [10,11].
Iron and vitamin D status are difficult
to interpret in obese children
Mild inflammation and excessive storage in the adipose
tissue impair adequate evaluation of body stores.
Iron supplementation should be cautiously used
when the ferritin level is low.
Nutritional and environmental risk factors of vitamin D
deficiency sought in obese children and adolescents,
and vitamin D status assessed [if] significant risk of
deficiency or showing evidence of early cardiovascular
or metabolic complications. Prevention of vitamin D
deficiency should follow the guidelines [of] the
general pediatric population, namely regular
supplementation with two doses of 80,000100,000 IU
every winter [10].
Hypercholesterolemia in children:
Why and how to screen for it?
Girardet JP, Bocquet A, Chouraqui JP, Darmaun D,
Feillet F, Frelut F, Hankard R, Rozé JC, Simeoni U,
Briend A, Dupont C, Committee on Nutrition of the
French Society of Paediatrics
Arch Pediatr. 2018 Mar 13. pii: S0929-693X(18)30048-4
Hypercholesterolemia in children:
Why and how to screen for it?
Atherosclerosis begins during childhood closely
related to the LDL cholesterol (LDL-C) [1].
Clinical cardiovascular (CV) complications of
hypercholesterolemia (HC) occur later in adulthood.
Screening and management of children with HC,
particularly in its most severe presentations, are
therefore part of the primary prevention of CV
diseases [2].
HC screening strategies in children evaluated by
prospective studies and reviewed in recent years [2
7].
This paper explains why plasma cholesterol should be
measured at least once in every child.
Hypercholesterolemia in children:
Why and how to screen for it?
HC : cholesterol above the 95
th
percentile in
the general pediatric population [2,3,6,7],
5% of children are hypercholesterolemic.
FH is severe: heterozygous subjects
probability of coronary heart disease before
age 50 : 20% (women), 50% (men) [8]. The risk
of coronary mortality before age 40 x125 in
women and x48 in men compared to the
general population [9].
Hypercholesterolemia in children:
Why and how to screen for it?
Screening 1.5- to 2-mL blood sample
fasting plasma total cholesterol, HDL
cholesterol, and triglyceride levels, and
calculation of LDL-C [3].
Committee of Nutrition of the French
Society of Pediatrics : all children living
in France be screened between 3 and 9
years of age [3].
Nutritional management of cows
milk allergy in children: An update
Dupont C, Chouraqui JP, Linglart A, Bocquet A,
Darmaun D, Feillet F, Frelut ML, Girardet JP, Hankard R,
Rozé JC, Simeoni jU, Briend A. Committee on Nutrition
of the French Society of Pediatrics
Arch Pediatr. 2018 Mar 22 pii: S0929-693X(18)30050-2.
Nutritional management of cows milk
allergy in children: An update
CMA, several types of digestive, cutaneous, and
respiratory symptoms, some appearing in the form of
syndromes, since risks and handling differ largely according to
syndromes.
Early diagnosis and timely elimination diet needed to avoid
growth retardation.
adapted formulas available in most industrialized countries
generally tolerated by a majority of infants with CMA, efficacy
not always proven by a clinical trial
In 2012, we regretted the absence of safety and nutritional
efficacy information for most of the products available.
Although this situation slightly improved, with more studies
focusing on allergic populations, still proper growth has not
been shown for many formulas. A formula with proven safety
and suitability in children with CMA should therefore be
privileged.
Nutritional management of cows milk
allergy in children: An update
Once solid foods are introduced, parents should be
carefully and regularly advised on how to adequately
replace dairy products and be aware that diversification
should not be restricted except in cases of other proven
food allergies
Likewise, parents still need dietary advice when CMA is
outgrown.
Baked milk largely helps feeding children with long
lasting CMA, but the appropriateness and timing of its
introduction should be individually and carefully
assessed by physicians.
An appropriate challenge under medical supervision is
needed to test the tolerance of baked milk in children
from one year of age.
Nutritional management of cows milk
allergy in children: An update
All children with CMA should have an assessment of
their calcium and vitamin D intakes and receive
counselling to reach RDA for these nutrients.
Counselling to caregivers and families should include
the importance of calcium intake, sources of dietary
calcium and the expected objectives and timeline.
The assessment of bone metabolism (BMD and
metabolic bone profile) is advised only in a small subset
of CMA patients with suspected bone fragility.
fracture(s), rickets, CMA associated with another
chronic disease or multiple FAs, association of low
calcium intake; low vitamin D intake; low energy intake,
period of rapid growth, persisting CMA such as during
EoE.
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
Darmaun D, Lapillonne A, Simeoni U, Picaud JC,
Rozé JC, Saliba E, Bocquet A, Jean-Pierre
Chouraqui JP, Dupont C, Feillet F, Frelut ML,
Girardet JP, Turck D, Briend A, Committee on
Nutrition of the French Society of Pediatrics
(CNSFP), French Society of Neonatology (SFN)
Arch Pediatr, in press 2018
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
For the very preterm infant, PN is the main
source of nutrient intake for the first 2 weeks of
life.
ultimate goal rate of growth close to fetus
during the third trimester of pregnancy optimal
brain growth.
cumulative energy and protein deficit during
hospital stay can lead to extra-uterine growth
restriction (EUGR).
more optimal nutrition though both enteral and
intravenous routes may prevent EUGR
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
association between growth rate in the
first few weeks and long term
neurodevelopment in retrospective,
observational studies.
subjected to multiple sources of bias,
correlation does not necessarily imply
a causal relationship, and paucity of of
prospective, randomized trials.
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
Amino acid supply the driver of growth,
and should be started from the time of birth,
if possible at rates recommended. room for
improvement in the composition of parenteral
amino acid mixtures.
Non-protein energy supply should combine
glucose and fat from the time of birth, and
primarily aims at covering brain requirements
for energy (glucose), and building materials
(poly-unsaturated fatty acids).
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
In children born preterm, whether the risk of
developing chronic disease at adulthood is linked
to catch-up growth occurring after extra-uterine
growth restriction, or to a poor qualityof
growth (suboptimal fat/lean body mass
accretion).
Optimized, personalizedrather than
aggressive’—intravenous nutrition may help
prevent both EUGR and suboptimal lean/fat mass
accretion, and may, in turn, improved long term
health outcomes.
Parenteral Nutrition for Preterm
Infants: Issues and Strategy
it appears reasonable to propose a more
optimal initial PN, and to follow the
recommended intakes.
Based on the current nutritional knowledge,
the prevention of the onset of EUGR can be
used as a surrogate and intermediate marker
of adequate nutrition.
More randomized trials
Futurs travaux
Ecritures en cours
Participation aux travaux de lANSES
Participation aux travaux du codex
alimentarius
Sujets dintérêt en commun avec le GFGHNP